Physiomics Share Discussion Threads

[spacedust] 23/4/2018 14:42

3rd mini tree shake.....double figure finish???

[margic] 23/4/2018 14:37

This is still what I call even trading. I.e still have sellers into the rises. For me the big sign is when it appears to just be a sea of blue. May get a really strong finish here with some strong buying. Strong buying not started yet considering the move. Bodes well for holders and those buying in now.

[margic] 23/4/2018 14:33

Expected this last week. Still happening, that's what matters. More tomorrow, let's see how strong she blows into close!

[bobdown2] 23/4/2018 14:29

And the news is good enough to warrant this rise. Looks very promising.

[markth126] 23/4/2018 14:26

Something must be driving this price!!

[hope67] 23/4/2018 14:24

Yep won't be excited until it clears 12p

[spacedust] 23/4/2018 14:06

7.5p!!! Now that's just for starters. Did someone say this morning gigantic rise coming??? I hope he is right

[margic] 23/4/2018 13:59

Yes, really good if you wanna see a 2-3 day pump

[tmmalik] 23/4/2018 13:55

Excitement will start from 10p

[spacedust] 23/4/2018 13:51

No one excited.....is that a good sign

[hope67] 23/4/2018 13:51

34ema and 8ema cross over,
higher highs,
rising rsi,
sp has crossed the 8ema
macd cross over all very bullish

[the stigologist] 23/4/2018 12:52

#BioTrinity2018 starts today (a major Bio/Pharma INVESTMENT and PARTNERING conference sponsored by likes of Glaxo , Lilly, Sanofi, Novartis etc etc )

Monday - Partnering meetings

Tuesday - Physiomics giving a Company Update

Wednesday - Government funding body Innovate UK holding a Presentation on how they plan to invest £0.5-1.5m a pop in projects from SMEs in Precision Medicine

[the stigologist] 23/4/2018 12:43

Chart looks amazing for a bowl to 15-30p

I think fundamentals justify 50-100p right now

Long term I will not rule out £10 per share

Just imagine having 1 million shares in this ?

[no24rton] 23/4/2018 12:29

looking good

[spacedust] 23/4/2018 12:29

This is the rise most of us have been waiting for. Finally!

[spacedust] 23/4/2018 11:50

Above 6.25p *

Oh there it goes. Could be lift off today. Gigantic move up coming

[spacedust] 23/4/2018 11:48

Another tick above and above 6p then the charts is off to a rocket

[the stigologist] 22/4/2018 14:04

PYC Physiomics (Share Price 6p ; Shares o/s 58m ; Mkt Cap £3.5m)

On November 30th 2017 the ex-Founder of Physiomics made the following points in a long post in which he also claimed he believed PYC should be worth over 100p+

*Collaborations with major pharmas have been constrained whilst the models are perfected and due to the secretive nature of all pharmas who generally speaking do not want to share data. The latest contract has dramatically increased the visibility of what PYC do and do best and will encourage a raft of Biotech analysts to write it up as more contracts are announced

* PYC is striving to personalised medicine The HOLY GRAIL with tremendous Social and Financial Implications.




Since then the Physiomics management have on a number of occasions talked about Personalised Medicine, Cloud technology, AI (Artificial Intelligence)

e.g. Interim Results February 2018



"We believe that the advent of more powerful computing solutions, including cloud-based technologies and AI and their increasing adoption within the life sciences industry is leading to a resurgence of interest in rational drug design and in the use of modelling more generally in the R&D process."

...

"This grant project, focused on the personalisation of oesophageal cancer treatment, has driven insights that may be integrated into our core Virtual Tumour offering and will also be the subject of thought capital that will be exploited over the course of this calendar year at industry conferences and through the publication of scientific papers in order to garner further interest from the drug research community. Finally, the ideas generated by this project have the potential to be taken forward in a further personalised medicine project for which the Company is currently seeking funding."

Having presented 'successfully' last week at the AACR conference in Chicago,US, this coming week they will present on Tuesday 24th April 2018 at BioTrinity in the UK (Europe's leading Investment and Partnering conference for the BioPharma industry). Following that their previous funding partners the Government Innovate UK body will be launching a Personalised Medicine investment accelerator looking to invest £0.5m-1.5m in projects run by SMEs.

Now clearly a £3m company like Physiomics winning a big funding contract like that would be both an immense validation of their technology and approach but also fund their in a NON-DILUTIVE manner for many years.

It's interesting that the UK Government is funding SMEs to tackle the Holy Grail of Personalised Medicine but there are other massive AI companies involved who could I suggest partner with Physiomics. Imagine £3m Physiomics announcing a deal with Jeff Bezos' $1bn+ cancer detection/personalised medicine start-up/roll-up Grail or how about with Google's UK AI specialist DeepMind (which they bought for $500m) and has an operation called DeepMind Health looking to work with Academics and the NHS for cancer detection/personalised medicine. This is something the market has not considered as of yet because they still see PYC as simply being a Company that will have biotechs and Pharmas as potential customers.





"GRAIL, Inc., a precision medicine and life sciences company aiming to develop new very early detection techniques for cancer, has attracted more than $900 million in investment capital from some of the most well-known names in pharmaceutical sales and development.

Bristol-Myers Squibb, Celgene, Merck, and Johnson & Johnson Innovations have joined with other strategic investors, including Amazon’s Jeff Bezos and McKesson Ventures, to contribute hundreds of millions to the company’s financial future.

“We envision a global community that benefits from early-stage cancer detection where fewer individuals face the anguish of late-stage diagnosis and devastating outcomes,” said Jeff Huber, GRAIL’s Chief Executive Officer.

“I believe that GRAIL’s approach leveraging high-intensity sequencing, population-scale clinical studies, and state of the art computer science and data science is unparalleled in the field of cancer detection."

[margic] 22/4/2018 14:02

If all plays out well then this is absolutely set for another whirlwind and this is still very early seating. The charts are set to blow or sink, the platform for speculation has been well and truly set, interest and volumes creeping up again, results on a couple of fronts due, market cap has been taken back towards old lows and just accounts in my opinion the lower end value of the last 3-6months worth of deals. The company is soon to post profitable for perhaps the first time ever, they are also now attending serious end meet ups, the brand has taken a major lift within the industry in just the last 6 months, the rot and poison players are now far gone, we have an industry young team mixing with other young high players from major firms, safe to assume these all crossed paths many times over the year including working together, PYC are starting to make their move with this technology now and when you compare to market caps of its likely rivals, where the market places PYC's tech now and how soon it can be proved against the higher caps, this represents a no brainer to me. £2.50p May sound completely unrealistic the fish bowl or higher magnet effect technically doesn't appear unrealstic but all be it, if for only a 5sec hold does a £135-140mil market valuation sound so silly? £1.5 for £80mil? 50p for £29mil? Roughly? I could think of many rns that could make a few of those happen. The fake one posted the other day would be good enough ;)

[spacedust] 21/4/2018 23:17

What Do you mean hope Not???
I want this at 300m market cap!!!

[hope67] 21/4/2018 14:43

Lets hope not I would expect some deal to be announced in the next 2 months

[the stigologist] 20/4/2018 23:22

There is a wall of Government and Corporate money hitting this market and PYC clearly a major player.

This will not stay at £3m market cap for long

[the stigologist] 20/4/2018 23:21

Particularly KTN the hosts of today's £50m AI precision medicine funding presentation

[the stigologist] 20/4/2018 23:20

Hmm is it just me or is Physiomics Twitter account following a few more accounts since last week?

[myamay16] 20/4/2018 22:53

Fake but forward thinking



19. Press Release v2 (Merck BHAG Realized) Merck’s “Virtual PipelineTM” Powers Decision Making Boston, MA, November 4, 2024 Merck released details today on a revolutionary platform that it created to support all aspects of the drug discovery and development process. This 10 year journey began in 2014 with the acknowledgement that the pharmaceutical industry must transform in order to survive the mounting financial and regulatory pressures. In collaboration with regulatory agencies world-wide, Merck created the Virtual PipelineTM by adopting a Product Lifecycle Management (PLM) mentality and completely and permanently altered the pharmaceutical research and development landscape. “The existence of the Virtual PipelineTM and the ability to fully simulate the entire lifecycles of therapeutic agents allowed our business development team to make an informed decision to acquire Iliad Pharmaceuticals’ entire portfolio with the intent to launch a drug that will see Merck re-enter the infectious disease therapeutic area. It is our expectation that Merck will enter the market with First and Best-in-Class agents grossing in excess of $10BN per annum.”, reported Dr. Hootie N.D. Blowfish, Head of Strategic Acquisitions. While too early to verify, Merck projects that the Virtual PipelineTM will enable their research scientists to reduce the time from target identification to product launch by as much as 40% with associated cost savings nearing 50%. Note: This is completely fake and does not represent any forward looking statements on behalf of Merck.